Tonix Pharmaceuticals Holding Corp.TNXPNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank93
3Y CAGR+5.6%
5Y CAGR+21.2%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+5.6%/yr
vs +43.7%/yr prior
5Y CAGR
+21.2%/yr
Recent deceleration
Acceleration
-38.0pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
2.6x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
2025$132.17M-4.9%
2024$139.03M+14.5%
2023$121.41M+8.3%
2022$112.09M+21.4%
2021$92.31M+82.9%
2020$50.48M+75.1%
2019$28.83M+9.5%
2018$26.32M+23.6%
2017$21.29M-45.4%
2016$38.97M-